Literature DB >> 25190368

Complementary/alternative and conventional medicine use amongst menopausal women: results from the Australian Longitudinal Study on Women's Health.

Wenbo Peng1, Jon Adams1, Louise Hickman1, David W Sibbritt2.   

Abstract

Large population-based studies of complementary and alternative medicine (CAM) and conventional medicine use amongst menopausal women are lacking. This study helps address this gap by analysing data from a nationally representative sample of 10011 Australian women aged 59-64 years. Overall, 39% of menopausal women consulted CAM practitioners, 75% used self-prescribed CAM, 95% consulted general practitioners (GP) and 50% consulted specialists during the previous year, and 12% were current hormone replacement therapy (HRT) users. Our findings suggest that CAM is a significant healthcare option utilized by women to treat menopausal symptoms, and so requires attention from GPs and specialists.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Complementary and alternative medicine; Hormone replacement therapy; Hysterectomy; Menopause; Oophorectomy; Surgical menopause

Mesh:

Substances:

Year:  2014        PMID: 25190368     DOI: 10.1016/j.maturitas.2014.08.002

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  3 in total

1.  Menopausal Hormone Therapy use and breast cancer risk by receptor subtypes: Results from the New South Wales Cancer Lifestyle and EvaluAtion of Risk (CLEAR) study.

Authors:  Usha Salagame; Emily Banks; Dianne L O'Connell; Sam Egger; Karen Canfell
Journal:  PLoS One       Date:  2018-11-07       Impact factor: 3.240

2.  Water Extract of Rhizoma Drynaria Selectively Exerts Estrogenic Activities in Ovariectomized Rats and Estrogen Receptor-Positive Cells.

Authors:  Liping Zhou; Ka-Ying Wong; Christina Chui-Wa Poon; Wenxuan Yu; Huihui Xiao; Chi-On Chan; Daniel Kam-Wah Mok; Man-Sau Wong
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-24       Impact factor: 5.555

3.  Use of Menopausal Hormone Therapy and Bioidentical Hormone Therapy in Australian Women 50 to 69 Years of Age: Results from a National, Cross-Sectional Study.

Authors:  Louiza S Velentzis; Emily Banks; Freddy Sitas; Usha Salagame; Eng Hooi Tan; Karen Canfell
Journal:  PLoS One       Date:  2016-03-23       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.